Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancerYoshinori Munemoto, Hideyuki Mishima, Keiichiro Ishibashi et al.|BMC Cancer|2015Cited by 18